{"id":1645,"date":"2022-04-26T04:34:11","date_gmt":"2022-04-26T04:34:11","guid":{"rendered":"https:\/\/telescopeinnovations.com\/?p=1645"},"modified":"2022-10-05T19:49:40","modified_gmt":"2022-10-05T19:49:40","slug":"telescope-expects-proposal-for-a-new-board-member-at-upcoming-agm","status":"publish","type":"post","link":"https:\/\/telescopeinnovations.com\/telescope-expects-proposal-for-a-new-board-member-at-upcoming-agm\/","title":{"rendered":"Telescope expects proposal for a new board member at upcoming AGM"},"content":{"rendered":"\n
Vancouver, BC \u2014 April 26, 2022 \u2014 Telescope Innovations Corp. (\u201cTelescope<\/strong>\u201d or the \u201cCompany<\/strong>\u201d) (CSE: TELI), a chemical technology company, announces that in connection with the Company\u2019s annual general meeting of shareholders scheduled to occur on April 28, 2022, management of the Company understands that a nomination from the floor will be made for the election of Henry Dubina as an additional independent director of the Company. The nomination of Mr. Dubina is supported by management and the Company recommends that shareholders vote in favour of the election of Mr. Dubina as a director of the Company.<\/p>\n\n\n\n Mr. Dubina was the president and Strategic Business Unit Head of Mettler-Toledo AutoChem (\u201cMT AutoChem<\/strong>\u201d) between 1999 and his retirement in 2022. As the President and Head of MT AutoChem for over 20 years, he directed the global business from Research & Development, Manufacturing, and Marketing, to Sales and Service. MT AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to accelerate the development of new, high-quality chemical and biological entities and processes. Technology platforms included automation, spectroscopy, sampling systems, particle size and shape measurement and calorimetry, software & machine learning algorithms. Prior to this time, Mr. Dubina developed and directed Applied Systems Inc., into a $15 million provider of in-situ spectroscopy systems (Fourier-transform infrared instruments) and related sampling and software (ReactIR) before its acquisition in 1999 by Mettler-Toledo International, Inc.<\/p>\n\n\n\n Jason Hein, CEO states, \u201cWe are looking forward to working with Henry and harvesting some of the valuable knowledge and guidance he brings to the table as we implement our corporate strategies and build on our strong governance.\u201d<\/em><\/p>\n\n\n\n About Telescope<\/strong><\/p>\n\n\n\n Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. A key area of application for these tools is the development of scalable manufacturing processes for mental health medicines in the under-utilized tryptamine class of compounds, including psychedelic therapeutics. Telescope also applies these toolsets to resolve inefficiencies in industrial process chemistry and manufacturing. Our aim is to bring modern chemical solutions to meet the most serious challenges in health and sustainability. <\/p>\n\n\n\n On behalf of the Board,<\/p>\n\n\n\n Telescope Innovations Corp.<\/strong><\/p>\n\n\n\n